CRP and benign neoplasm: Second, unlike IVs such as variants on the C-reactive protein gene which encodes C-reactive protein (Burgess et al., 2017; Reactive Protein Coronary Heart Disease Genetics Collaboration et al., 2011), the exact biological pathways through which FTO affect adiposity are not fully understood, which complexifies the assessment of pleiotropy.